The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Keros Therapeutics, Inc(NASDAQ:KROS) 
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, wh...
Website: http://www.kerostx.com
Founded: 2015
Full Time Employees: 32
CEO: Jasbir S. Seehra
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Keros Therapeutics Days Payable Outstanding ttm (DPO)
Keros Therapeutics Days Receivable Outstanding ttm (DSO)
Keros Therapeutics Days Inventory Outstanding ttm (DIO)
Keros Therapeutics Op Cashflow Per Share ttm
Keros Therapeutics Free Cashflow Per Share ttm
Keros Therapeutics Cash Per Share ttm
Keros Therapeutics P/S ratio ttm
Keros Therapeutics (GAAP) P/E ratio ttm
Keros Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.